Two new analyses reinforce consistent efficacy of Novartis therapy Gilenya across wide range of relapsing MS patients

Two new analyses reinforce consistent efficacy of Novartis therapy Gilenya across wide range of relapsing MS patients

May 31, 2012
Source URL: https://qa1.novartis.us/us-en/news/media-releases/two-new-analyses-reinforce-consistent-efficacy-novartis-therapy-gilenya-across-wide-range-relapsing-ms-patients-0

List of links present in page
  1. https://qa1.novartis.us/us-en/us-en/news/media-releases/two-new-analyses-reinforce-consistent-efficacy-novartis-therapy-gilenya-across-wide-range-relapsing-ms-patients-0